(EMAILWIRE.COM, June 09, 2021 ) The use of combination drugs for the treatment of asthma and COPD is increasing. This is due to the greater impact on patient reported outcomes (PROs) compared to monotherapies. For example, combination of short acting beta agonists (SABA) and short acting muscarinic antagnoists (SAMA) are superior compared to either medication alone in improving lung function. The use of combination long acting beta agonists (LABA), and long acting muscarnic antagonists (LAMA) have improved lung function than long acting monotherapy bronchodilators.
Many inhalers that do not use chlorofluorocarbons (CFC) are already available for the treatment of asthma and chronic obstructive pulmonary disease.
The anti-asthmatics and chronic obstructive pulmonary disease (COPD) market consists of sales of anti-asthmatics and chronic obstructive pulmonary disease (COPD) drugs which are used to relieve the frequency of acute attacks of asthma, emphysema, chronic bronchitis, and nocturnal awakenings. The class of drugs includes Bronchodilators, anti-inflammatory drugs, monoclonal antibodies and combination drugs.
Anti-Asthmatics And COPD Drugs Market Report Segments:
1) By Drug Class: Bronchodilators, Anti-inflammatory Drugs, Monoclonal Antibodies, Combination Drugs.
2) By End User: Asthma Patients, COPD Patients.
3) By Distribution Channel: Hospital Pharmacies, Private Clinics, Drug Stores, Retail Pharmacies, E-Commerce.
Read More On The Global Anti-Asthmatics And COPD Drugs Market Report:
http://www.thebusinessresearchcompany.com/report/anti-asthmatics-and-COPD-drugs-market
Anti-Asthmatics And COPD Drugs Market Size Forecast:
The global anti-asthmatics and COPD drugs market is expected to grow from $52 billion in 2019 to $77.3 billion in 2020 at a compound annual growth rate (CAGR) of 48.8%. The respiratory drugs market witnessed significant growth mainly due to the COVID-19 outbreak. The fact that COVID-19 is essentially a respiratory ailment has boosted the market growth. The market is then expected to grow at a CAGR of 5.7% from 2021 and reach $83.8 billion in 2023.
Major Players in the Anti-Asthmatics And COPD Drugs Market:
Novartis AG
Merck & Co
GlaxoSmithKline
Boehringer Ingelheim Gmbh
AstraZeneca, Roche
Teva Pharmaceutical
Vectura
Pfizer
Abbott
Request For A Sample:
http://www.thebusinessresearchcompany.com/sample.aspx?id=2417&type=smp
Anti-Asthmatics And COPD Drugs Market – By Type Of Therapy (Preventive, Curative), By Drug Class (Bronchodilators, Anti-Inflammatory Drugs, Monoclonal Antibodies, Combination Drugs), By Distribution Channel (General Pharmacies, Hospital Pharmacies, Online Retailers), By End-Users (Asthma Patients, COPD Patients), And By Region, Opportunities And Strategies Global Forecast To 2030 is one of a series of new reports from The Business Research Company that provide market overviews, analyze and forecast market size and growth for the whole market, anti-asthmatics and COPD drugs market segments and geographies, anti-asthmatics and COPD drugs market trends, drivers, restraints, leading competitors revenues, profiles and market shares in over 1,000 industry reports, covering over 2,500 market segments and 60 geographies.
The report also gives in-depth analysis of the impact of COVID-19 on the market. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. A highly experienced and expert team of analysts and modelers provides market analysis and forecasts. The reports identify top countries and segments for opportunities and strategies based on market trends and leading competitors approaches.
Here Is A List Of Reports Similar To The Anti-Asthmatics And COPD Drugs Global Market Report By The Business Research Company:
Oncology Drugs Market – By Type (Blood Cancer, Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Cervical Cancer, Kidney Cancer, Gastric Cancer, Brain Tumor, Skin Cancer, Ovarian Cancer, Bladder Cancer, Pancreatic Cancer, Thyroid Cancer, Others), By Drug Class Type (Targeted Therapy, Immunotherapy (Biologic Therapy), Chemotherapy, Hormonal Therapy), By Distribution Channel (Retail Pharmacies/Drug Stores, Hospital Pharmacies, Others), By Route Of Administration (Oral, Parenteral, Others), By Drug Classification (Branded, Generic), And By Region, Opportunities And Strategies – Global Forecast To 2030
http://www.thebusinessresearchcompany.com/report/oncology-drugs-market
Ophthalmology Drugs Market – By Type (Antiglaucoma Drugs, Dry Eye Medication And Other Ophthalmological Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores And Others), By Drug Classification (Branded Drugs And Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs) And, By Region, Opportunities And Strategies Global Forecast To 2030
http://www.thebusinessresearchcompany.com/report/ophthalmology-drugs-market
Pharmaceutical Drugs Market – By Segments (Musculoskeletal Disorders Drugs, Cardiovascular Drugs, Oncology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Central Nervous System Drugs, Genito-Urinary Drugs, Respiratory Diseases Drugs, Gastrointestinal Drugs, Hematology Drugs, Dermatology Drugs, Ophthalmology Drugs), And By Region, Opportunities And Strategies Global Forecast To 2030
http://www.thebusinessresearchcompany.com/report/pharmaceutical-drugs-market
Interested to know more about The Business Research Company?
Read more about us at
http://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx
The Business Research Company is a market research and intelligence firm that excels in company, market, and consumer research. It has over 200 research professionals at its offices in India, the UK and the US, as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.
Call us now for personal assistance with your purchase:
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
The Business Research Company
Email: info@tbrc.info
Follow us on LinkedIn: http://bit.ly/3b7850r
Follow us on Twitter: http://bit.ly/3b1rmjS
Check out our Blog: http://blog.tbrc.info/
Marketing TBRC
+91 8897263534
Marketing@tbrc.info
Source: EmailWire.Com 
